This inventor holds 1 USPTO granted patent. Top assignee: Oy Juvantia Pharma Ltd.. Active years: 2004.
Company Filing History:
Years Active: 2004
Title: Timo A Lakka: Innovator in Genetic Research
Introduction
Timo A Lakka is a notable inventor based in Kuopio, Finland. He has made significant contributions to the field of genetic research, particularly in the area of adrenoceptor proteins. His work has implications for understanding vascular conditions and potential treatments.
Latest Patents
Timo A Lakka holds a patent for a DNA molecule encoding a variant α2B-adrenoceptor protein and its uses. This invention relates to a DNA sequence that comprises a nucleotide sequence encoding a variant α-adrenoceptor protein. It also includes a method for screening subjects to determine if they are carriers of a variant gene that encodes this protein. Furthermore, the invention outlines a method for treating mammals suffering from vascular contraction of coronary arteries by administering a selective α-adrenoceptor antagonist. The patent also covers transgenic animals that contain a human DNA molecule encoding the human α-adrenoceptor protein or the variant α-adrenoceptor protein. He has 1 patent to his name.
Career Highlights
Timo A Lakka is associated with Oy Juvantia Pharma Ltd., where he continues to advance his research and innovations. His work is pivotal in the development of new therapeutic strategies for cardiovascular conditions.
Collaborations
He collaborates with notable colleagues such as Amir Snapir and Paula Heinonen, contributing to a dynamic research environment that fosters innovation.
Conclusion
Timo A Lakka's contributions to genetic research and his patented innovations highlight his role as a key figure in the scientific community. His work not only enhances our understanding of genetic variations but also paves the way for potential medical advancements.